Skip to main content
Carey Anders, MD, Oncology, Durham, NC

CareyKernodleAndersMD

Oncology Durham, NC

Hematologic Oncology

Professor of Medicine, Duke Cancer Institute, Durham, NC

Dr. Anders is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Anders' full profile

Already have an account?

  • Office

    2 Seeley Mudd, 10 Bryan Searle Drive
    Durham, NC 27710
    Phone+1 919-684-8111

Summary

  • Dr. Carey K. Anders is the Medical Director of the Duke Brain and Spine Metastases Program and a member of the Neuro-Oncology (primary) and Breast Cancer (secondary) Programs within the Duke Cancer Institute. Dr. Anders is a leading expert in the clinical care of patients with breast cancer of all stages, with a research focus in breast cancer that spreads to the central nervous system (CNS).

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2002 - 2005
  • Brody School of Medicine at East Carolina University
    Brody School of Medicine at East Carolina UniversityClass of 2002

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2002 - 2025

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Could MRI Help Detect Brain Metastases from Breast Cancer?
    Could MRI Help Detect Brain Metastases from Breast Cancer?October 10th, 2022
  • White Glove Service for Brain and Spine Metastasis Patients
    White Glove Service for Brain and Spine Metastasis PatientsAugust 25th, 2022
  • For Small Brain Metastases, Stereotactic Radiosurgery Alone Was Found to Lead to Less Cognitive Deterioration Than Whole Brain Radiotherapy plus the Stereotactic Radiosurgery
    For Small Brain Metastases, Stereotactic Radiosurgery Alone Was Found to Lead to Less Cognitive Deterioration Than Whole Brain Radiotherapy plus the Stereotactic RadiosurgerySeptember 8th, 2016